Keytruda is a medication used to treat various types of cancer. The cost of Keytruda can be a concern for patients and their families, as it is an expensive medication. The cost of Keytruda can vary depending on factors such as the dosage and the length of treatment.

The cost of Keytruda can be covered by insurance, and there are programs available to help patients who may not be able to afford the medication. Merck, the company that produces Keytruda, offers financial support to eligible patients through their Merck Access Program. This program provides co-pay assistance and support for uninsured patients. Patients can apply for this program online, and eligibility requirements can be found on the program's website [3].

However, insurance coverage for Keytruda can vary depending on the patient's insurance plan. Some insurance plans may have restrictions on the use of Keytruda, such as requiring prior authorization or limiting the number of doses that can be covered. Patients should check with their insurance provider to determine the coverage limits for Keytruda under their plan.

In addition, the availability of generic versions of Keytruda may affect insurance coverage and cost in the future. As of now, there are no generic versions of Keytruda available [1].

Overall, while insurance coverage for Keytruda can vary, there are programs available to help patients afford the medication. Patients should check with their insurance provider and explore these programs to determine the best options for their individual situation.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/KEYTRUDA
[2] https://www.keytruda.com/financial-support/
[3] https://www.merckaccessprogram-keytruda.com/hcc/affordability.html